AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2016
Nov 9, 2016
30786_dirs_2016-11-08_9bdf949b-3b60-4763-936d-164433ae7da7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-11-04
Reporting Person: Hall Shannon (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-04 | Bio-Rad A Common Stock | M | 220 | — | Acquired | 1474.1053 | Direct |
| 2016-11-07 | Bio-Rad A Common Stock | S | 84 | $165.62 | Disposed | 1390.1053 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-04 | Restricted Stock Units | $0 | M | 220 | Disposed | Bio-Rad A Common Stock (220) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 13.0933 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/30/16.
F3: Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: The restricted stock units vest in five equal annual installments beginning November 4, 2012.